Search results for: Chris Skedgel
Filter search results
Chris Skedgel
15 July 2019
Dr Chris Skedgel has over 25 years of applied health economics experience in consulting and academia. His interests centre on the use of health economics to maximise the societal value…
OHE at ISPOR Europe 2024
17 November 2024, 8:00am
…Should Health Technology Assessment Include the Bereavement Effect on Health-Related Quality of Life? What Difference Could It Make to Decisions About Life-Extending Treatments? Chris Skedgel (moderator) 10:15 – 11:15 Issue…
Accounting for Preference Heterogeneity in Discrete Choice Experiments
4 May 2022
…used to address your research questions, please get in touch with Chris Skedgel or David Mott. Citation Vass, C., Boeri, M., Karim, S., Marshall, D., Craig, B., Ho, K.-A., Mott,…
OHE is Pleased to Announce the Appointment Two New Economists: Marina Rodes Sanchez and Chris Sampson
12 October 2017
Marina and Chris have both joined the OHE in October 2017. Marina joins following completion of her MSc in Health Economics (City, University of London) and Chris joins from the…
Chris Sampson
9 October 2017
Chris is an expert in economic evaluation. His research focuses on significant methodological and policy challenges relating to the value of interventions and programmes for health. At OHE, Chris’s research…
Chris Henshall
14 December 2016
Dr Chris Henshall is an Honorary Professor at HERG. Chris has held various academic and senior management positions within the health research system and the higher education system within the…
Virtual ISPOR European 2020
10 November 2020
…aspects of end-of-life care Chris Skedgel, PhD, MDE Associate Director, Office of Health Economics Presenter Using discrete choice methods, Chris and his co-author find that a majority of the public…
Christopher Henshall
30 August 2023
Christopher Henshall Ph.D. has worked in universities, research funding bodies and the UK Civil Service, including positions at the UK Medical Research Council, the Department of Health and the NHS…
Ethical and Economic Issues in the Appraisal of Medicines for Ultra-rare (or Ultra-orphan) Conditions
13 January 2020
…under the HST process could lead to inequalities in access and health outcomes for patients with ultra-rare conditions. A new OHE Consulting Report by Nadine Henderson, Maria Errea, Chris Skedgel,…